Launch & scale global trials at market speed
As cardiometabolic pipelines expand, sponsors need to launch global studies in weeks, not months. Medable is built to help sponsors and CROs scale across indications, execute faster, and bring therapies to patients sooner.
Move at market speed with data consistency that scales
- 1–2 week go-live with reusable program assets
- First study in 4–6 weeks with AI-assisted build, then 1–2 day UAT
- Asset catalog reused portfolio-wide — dashboards, eCOA, translations
- Real-time oversight with custom, on-demand exports
- 95% participant adherence across global enterprise studies
- eCOA, eConsent, and TeleVisit in one BYOD-compatible app
2K+
24K+
52
86
Cut initial study build timelines to two weeks or less with a program-led approach.
.gif)
Establish your standard
Make the operational investment once. Define reusable study components, translations, and integrations as your enterprise standard.
Adapt and configure
Scale a single molecule across multiple indications with a reusable operational framework.
Accellerate delivery across program
From onboarding participants to data visualization, our platform delivers the flexibility and efficiency you need for today’s clinical research demands.
Built to match the momentum of cardiometabolic
faster first-time eCOA build vs. manual, with AI-assisted configuration and localization
reduction in initial study build time — roughly 80 hours saved per study
reduction in country go-lives by running translations in parallel for simultaneous global launch
Operational AI for modern metabolic development
Medable’s AI helps your team process more data, faster, with human oversight and audit controls built in.
We have successfully completed the study with an impressive dosing compliance rate of 94.5%. To put this into perspective, our previous Sleep Apnea study had a compliance rate of 85–87%. This remarkable improvement is a testament to our strong partnership..."
How a Top-10 Pharma standardized weight management trials and beat FPI by six weeks
Learn how a top-10 pharmaceutical company partnered with Medable to standardize a complex global weight management program spanning 70+ sites, accelerate study startup, improve the participant and site experience, and achieve First Patient In (FPI) six weeks ahead of schedule.